Latest Infratil (NZX:IFT) News

CDC’s independent valuation jumped 23.6% to a mid-point of A$18.5 billion, propelled by contracted capacity exceeding 1GW and a major pipeline expansion to 3.9GW. Infratil’s nearly 50% stake now values at over A$9.2 billion.

Dealmaking and capital moves drove the week in financials, while one regulatory shock hit hard. PEXA slumped, but Magellan, Euroz Hartleys and several smaller finance names rose on mergers, asset sales and balance-sheet updates.

Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.

Speculative small caps drove the week, with Tasman Resources, Solis Minerals and Lithium Energy leading the board after funding, drilling and asset sale updates. At the other end, ASX Ltd and Arafura Rare Earths fell hard as investors reacted to higher costs and fresh equity issuance.

Infratil posted an 11% rise in operational EBITDAF to NZ$989 million in FY26, fuelled by a record 555MW CDC data centre contract and a 170% EBITDAF jump at Longroad Energy. The company refined its portfolio with over NZ$600 million in divestments and secured a BBB+ credit rating, underpinning a strong FY27 outlook.